$30.26
0.36% day before yesterday
NYSE, Jun 06, 10:10 pm CET
ISIN
US0718131099
Symbol
BAX

Baxter International Stock price

$30.26
+0.33 1.10% 1M
-1.54 4.84% 6M
+1.10 3.77% YTD
-3.06 9.18% 1Y
-58.52 65.92% 5Y
-4.80 13.70% 10Y
+10.20 50.83% 20Y
NYSE, Closing price Fri, Jun 06 2025
+0.11 0.36%
ISIN
US0718131099
Symbol
BAX
Sector

Key metrics

Market capitalization $15.53b
Enterprise Value $23.31b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 86.01
EV/Sales (TTM) EV/Sales 1.96
P/S ratio (TTM) P/S ratio 1.31
P/B ratio (TTM) P/B ratio 2.19
Dividend yield 3.44%
Last dividend (FY24) $1.04
Revenue growth (TTM) Revenue growth -20.17%
Revenue (TTM) Revenue $11.89b
EBIT (operating result TTM) EBIT $776.00m
Free Cash Flow (TTM) Free Cash Flow $271.00m
Cash position $2.29b
EPS (TTM) EPS $-1.08
P/E forward 24.94
P/S forward 1.36
EV/Sales forward 2.05
Short interest 4.43%
Show more

Is Baxter International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Baxter International Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Baxter International forecast:

6x Buy
30%
12x Hold
60%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Baxter International forecast:

Buy
30%
Hold
60%
Sell
10%

Financial data from Baxter International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
11,889 11,889
20% 20%
100%
- Direct Costs 7,526 7,526
21% 21%
63%
4,363 4,363
19% 19%
37%
- Selling and Administrative Expenses 2,858 2,858
13% 13%
24%
- Research and Development Expense 625 625
5% 5%
5%
930 930
36% 36%
8%
- Depreciation and Amortization 154 154
26% 26%
1%
EBIT (Operating Income) EBIT 776 776
38% 38%
7%
Net Profit -560 -560
121% 121%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about Baxter International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Baxter International Stock News

Neutral
Business Wire
12 days ago
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be availab...
Positive
24/7 Wall Street
23 days ago
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
Neutral
Seeking Alpha
about one month ago
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and managem...
More Baxter International News

Company Profile

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Head office United States
CEO D. Shafer
Employees 38,000
Founded 1931
Website www.baxter.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today